Biocept, Inc. (BIOC) Q4 2020 Results Conference Call March 29, 2021 4:30 PM ET
Company Participants
Jody Cain - LHA
Michael Nall - CEO, President & Director
Timothy Kennedy - CFO, SVP, Operations & Corporate Secretary
Michael Dugan - SVP, Chief Medical Officer & Medical Director
Conference Call Participants
Michael Okunewitch - Maxim Group
Operator
Good day, and welcome to the Biocept Fourth Quarter Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]. Please note this event is being recorded.
I would now like to turn the conference over to Jody Cain. Please go ahead, ma'am.
Jody Cain
This is Jody Cain with LHA. Thank you for participating in today's conference call. Joining me from Biocept are Michael Nall, President and Chief Executive Officer; Tim Kennedy, Chief Operating Officer and Chief Financial Officer; and Dr. Michael Dugan, Senior Vice President, Chief Medical Officer and Medical Director.
During this call, management will be making a number of forward-looking statements within the meaning of the private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and generally can be identified by terms such as anticipates, estimates, believes, could, expects, intends, may, plans, potential, predicts, projects, should, well, would or the negative of those terms. Forward-looking statements involve known and unknown risks and uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those statements as well as performance or achievements that are implied by the forward-looking statements.
In particular, there is significant uncertainty about the duration, severity and contemplated impact of the COVID-19 pandemic. This means results could change at any time and the contemplated impact of COVID-19 on Biocept's operations, financial results and
- Read more current BIOCQ analysis and news
- View all earnings call transcripts